Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward

Volume: 25, Issue: 5, Pages: 1076 - 1094
Published: May 1, 2017
Abstract
Over the past 20 years, there has been tremendous progress in retinal gene therapy. The safety and efficacy results in one early-onset severe blinding disease may lead to the first gene therapy drug approval in the United States. Here, we review how far the field has come over the past two decades and speculate on the directions that the field will take in the...
Paper Details
Title
Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward
Published Date
May 1, 2017
Volume
25
Issue
5
Pages
1076 - 1094
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.